 | • レポートコード：MRC-IM30131 • 出版社/出版日：IMARC / 2022年10月 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥374,850 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥674,850 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2021年95.4億ドルであった世界の循環腫瘍細胞（CTC）市場規模が2027年には182.4億ドルに達し、予測期間中、年平均10.70％成長すると予測しています。本調査レポートでは、循環腫瘍細胞（CTC）の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、技術別（CTC検出・濃縮法、CTC直接検出法、CTC分析）分析、用途別（臨床/リキッドバイオプシー、研究）分析、製品別（キット・試薬、採血チューブ、機器・システム）分析、標本別（血液、骨髄、その他体液）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。また、こちらの調査レポートに掲載されている企業情報には、BioFluidica Inc, Creatv MicroTech Inc., CytoLumina Technologies Corp., Fluxion Biosciences Inc., Greiner Bio-One International GmbH, Ikonisys Inc, Menarini Silicon Biosystems, Miltenyi Biotec, Qiagen N.V, Rarecells Diagnosticsなどが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界の循環腫瘍細胞（CTC）市場規模：技術別 - CTC検出・濃縮法循環腫瘍細胞（CTC）の市場規模 - CTC直接検出法循環腫瘍細胞（CTC）の市場規模 - CTC分析循環腫瘍細胞（CTC）の市場規模 ・世界の循環腫瘍細胞（CTC）市場規模：用途別 - 臨床/リキッドバイオプシーにおける市場規模 - 研究における市場規模 ・世界の循環腫瘍細胞（CTC）市場規模：製品別 - 循環腫瘍細胞（CTC）キット・試薬の市場規模 - 循環腫瘍細胞（CTC）採血チューブの市場規模 - 循環腫瘍細胞（CTC）機器・システムの市場規模 ・世界の循環腫瘍細胞（CTC）市場規模：標本別 - 血液標本における市場規模 - 骨髄標本における市場規模 - その他体液標本における市場規模 ・世界の循環腫瘍細胞（CTC）市場規模：地域別 - 北米の循環腫瘍細胞（CTC）市場規模 - アジアの循環腫瘍細胞（CTC）市場規模 - 欧州の循環腫瘍細胞（CTC）市場規模 - 中南米の循環腫瘍細胞（CTC）市場規模 - 中東・アフリカの循環腫瘍細胞（CTC）市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global circulating tumor cells (CTC) market size reached US$ 9.54 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 18.24 Billion by 2027, exhibiting a growth rate (CAGR) of 10.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Circulating tumor cells (CTC) are cancer cells that split away from the primary tumor and appear in the circulatory system as singular units or clusters. They have different biological phenotypes, such as epithelial, mesenchymal, and mixed epithelial-mesenchymal. CTC levels in a patient’s blood can allow early detection of cancer and act as a prognostic indicator. As they are in minimal quantity, several technologies are used for the isolation, enrichment, and detection of CTC, such as immunocapture, size-based separation, density-based separation, and microscopy. It also has wide-ranging applications in liquid biopsy, cancer research, drug development, and clinical biomarkers.
Circulating Tumor Cells (CTC) Market Trends:
The increasing prevalence of cancer due to genetic disorders, rising alcohol consumption, and rapid lifestyle changes are key factors driving the market growth. CTC assists in the early identification and real-time monitoring of lung, breast, digestive tract, and prostate cancer. In line with this, the increasing utilization of CTC in patient screening for metastasis and preclinical studies of new cancer drugs is favoring the market growth. Furthermore, the growing demand for minimally invasive (MI) diagnostic procedures and widespread adoption of CTC-based liquid biopsy to enable rapid recovery and limit trauma are providing a considerable boost to the market growth. Apart from this, the introduction of nanotechnology to improve the sensitivity and efficiency of CTC isolation and detection is providing an impetus to market growth. Moreover, increasing utilization in medical research to develop cell culture models for drug screening, disease modeling, genome editing, and tumor immunity is creating a positive outlook for the market. Additionally, the increasing awareness amongst healthcare professionals and patients about the importance of early cancer diagnosis is positively influencing the market growth. Other factors, including rapid advancements in biomedical imaging and bioengineering technology, extensive research and development (R&D) activities, and the rising demand for preventive medicine and companion diagnostics, are anticipated to drive the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global circulating tumor cells (CTC) market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on technology, application, product, specimen and end user.
Breakup by Technology:
CTC Detection and Enrichment Method
CTC Direct Detection Methods
CTC Analysis
Breakup by Application:
Clinical/Liquid Biopsy
Risk Assessment
Screening and Monitoring
Research
Cancer Stem Cell and Tumorigenesis Research
Drug/Therapy Development
Breakup by Product:
Kits and Reagents
Blood Collection Tubes
Devices and Systems
Breakup by Specimen:
Blood
Bone Marrow
Other Body Fluids
Breakup by End User:
Hospital and Clinics
Research and Academic Institutes
Diagnostic Centres
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being BioFluidica Inc, Creatv MicroTech Inc., CytoLumina Technologies Corp., Fluxion Biosciences Inc., Greiner Bio-One International GmbH, Ikonisys Inc, Menarini Silicon Biosystems, Miltenyi Biotec, Qiagen N.V, Rarecells Diagnostics and Stemcell Technologies.
Key Questions Answered in This Report:
How has the global circulating tumor cells (CTC) market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global circulating tumor cells (CTC) market?
What are the key regional markets?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the application?
What is the breakup of the market based on the product?
What is the breakup of the market based on the specimen?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global circulating tumor cells (CTC) market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Circulating Tumor Cells (CTC) Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Technology
6.1 CTC Detection and Enrichment Method
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 CTC Direct Detection Methods
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 CTC Analysis
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Application
7.1 Clinical/Liquid Biopsy
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Risk Assessment
7.1.2.2 Screening and Monitoring
7.1.3 Market Forecast
7.2 Research
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 Cancer Stem Cell and Tumorigenesis Research
7.2.2.2 Drug/Therapy Development
7.2.3 Market Forecast
8 Market Breakup by Product
8.1 Kits and Reagents
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Blood Collection Tubes
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Devices or Systems
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Specimen
9.1 Blood
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Bone Marrow
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Other Body Fluids
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by End User
10.1 Hospital and Clinics
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Research and Academic Institutes
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Diagnostic Centres
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 BioFluidica Inc
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.2 Creatv MicroTech Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.3 CytoLumina Technologies Corp.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.4 Fluxion Biosciences Inc.
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.5 Greiner Bio-One International GmbH
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.6 Ikonisys Inc
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7 Menarini Silicon Biosystems
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.8 Miltenyi Biotec
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.9 Qiagen N.V
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.10 Rarecells Diagnostics
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 Stemcell Technologies
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
Figure 2: Global: Circulating Tumor Cells Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Circulating Tumor Cells Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Circulating Tumor Cells Market: Breakup by Technology (in %), 2021
Figure 5: Global: Circulating Tumor Cells Market: Breakup by Application (in %), 2021
Figure 6: Global: Circulating Tumor Cells Market: Breakup by Product (in %), 2021
Figure 7: Global: Circulating Tumor Cells Market: Breakup by Specimen (in %), 2021
Figure 8: Global: Circulating Tumor Cells Market: Breakup by End User (in %), 2021
Figure 9: Global: Circulating Tumor Cells Market: Breakup by Region (in %), 2021
Figure 10: Global: Circulating Tumor Cells (CTC Detection and Enrichment Method) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Circulating Tumor Cells (CTC Detection and Enrichment Method) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Circulating Tumor Cells (CTC Direct Detection Methods) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Circulating Tumor Cells (CTC Direct Detection Methods) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Circulating Tumor Cells (CTC Analysis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Circulating Tumor Cells (CTC Analysis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Circulating Tumor Cells (Clinical/Liquid Biopsy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Circulating Tumor Cells (Clinical/Liquid Biopsy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Circulating Tumor Cells (Research) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Circulating Tumor Cells (Research) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Circulating Tumor Cells (Kits and Reagents) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Circulating Tumor Cells (Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Circulating Tumor Cells (Blood Collection Tubes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Circulating Tumor Cells (Blood Collection Tubes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Circulating Tumor Cells (Devices or Systems) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Circulating Tumor Cells (Devices or Systems) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Circulating Tumor Cells (Blood) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Circulating Tumor Cells (Blood) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Circulating Tumor Cells (Bone Marrow) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Circulating Tumor Cells (Bone Marrow) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Circulating Tumor Cells (Other Body Fluids) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Circulating Tumor Cells (Other Body Fluids) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Circulating Tumor Cells (Hospital and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Circulating Tumor Cells (Hospital and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Circulating Tumor Cells (Research and Academic Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Circulating Tumor Cells (Research and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Circulating Tumor Cells (Diagnostic Centres) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Circulating Tumor Cells (Diagnostic Centres) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: North America: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: North America: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: United States: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: United States: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Canada: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Canada: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Asia-Pacific: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Asia-Pacific: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: China: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: China: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Japan: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Japan: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: India: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: India: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: South Korea: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: South Korea: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Australia: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Australia: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Indonesia: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Indonesia: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Others: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Others: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Europe: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Europe: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Germany: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Germany: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: France: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: France: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: United Kingdom: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: United Kingdom: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Italy: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Italy: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Spain: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Spain: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Russia: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Russia: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Others: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Others: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Latin America: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Latin America: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Brazil: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Brazil: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Mexico: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Mexico: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Others: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Others: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Middle East and Africa: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Middle East and Africa: Circulating Tumor Cells Market: Breakup by Country (in %), 2021
Figure 86: Middle East and Africa: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Global: Circulating Tumor Cells Industry: SWOT Analysis
Figure 88: Global: Circulating Tumor Cells Industry: Value Chain Analysis
Figure 89: Global: Circulating Tumor Cells Industry: Porter's Five Forces Analysis